Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article
Authors
Keywords
-
Journal
Biomedicines
Volume 8, Issue 7, Pages 227
Publisher
MDPI AG
Online
2020-07-20
DOI
10.3390/biomedicines8070227
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population
- (2020) Giacomo Boffa et al. CNS DRUGS
- Neural sphingosine 1-phosphate accumulation activates microglia and links impaired autophagy and inflammation
- (2019) Indulekha Karunakaran et al. GLIA
- Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases
- (2019) Sara Grassi et al. Frontiers in Pharmacology
- Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial
- (2019) Jeffrey A Cohen et al. LANCET NEUROLOGY
- Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial
- (2019) Giancarlo Comi et al. LANCET NEUROLOGY
- Sphingosine 1‐phosphate but not Fingolimod protects neurons against excitotoxic cell death by inducing neurotrophic gene expression in astrocytes
- (2019) Collin Tran et al. JOURNAL OF NEUROCHEMISTRY
- Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model
- (2019) Agnes E. Nystad et al. JOURNAL OF NEUROIMMUNOLOGY
- Clinical activity after fingolimod cessation: disease reactivation or rebound?
- (2018) J. Frau et al. EUROPEAN JOURNAL OF NEUROLOGY
- Sphingosine 1-Phosphate and Atherosclerosis
- (2018) Makoto Kurano et al. Journal of Atherosclerosis and Thrombosis
- Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
- (2018) Ludwig Kappos et al. LANCET
- Factors Predictive of Severe Multiple Sclerosis Disease Reactivation After Fingolimod Cessation
- (2018) Ugur Uygunoglu et al. NEUROLOGIST
- Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis
- (2018) Shushu Wang et al. MEDICAL SCIENCE MONITOR
- Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study
- (2018) Jeffrey A Cohen et al. Multiple Sclerosis Journal
- Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis
- (2018) Tanuja Chitnis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inactivation of sphingosine-1-phosphate receptor 2 (S1PR2) decreases demyelination and enhances remyelination in animal models of multiple sclerosis
- (2018) Maryam S. Seyedsadr et al. NEUROBIOLOGY OF DISEASE
- Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination
- (2017) SunJa Kim et al. GLIA
- Sphingosine Kinase 1 and Sphingosine-1-Phosphate Signaling in Colorectal Cancer
- (2017) Yonghua Bao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation
- (2017) Veit Rothhammer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1) and receptor-5 (S1P5) agonist with autoimmune disease-modifying activity
- (2016) F L Scott et al. BRITISH JOURNAL OF PHARMACOLOGY
- Implication of sphingosin-1-phosphate in cardiovascular regulation
- (2016) Ningjun Li Frontiers in Bioscience-Landmark
- TGF-β/SMAD3 Pathway Stimulates Sphingosine-1 Phosphate Receptor 3 Expression
- (2016) Jiawei Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis
- (2016) Antonietta Gentile et al. Journal of Neuroinflammation
- The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures
- (2016) Catherine O’Sullivan et al. Journal of Neuroinflammation
- Sphingosine-1-Phosphate (S1P) Impacts Presynaptic Functions by Regulating Synapsin I Localization in the Presynaptic Compartment
- (2016) L. Riganti et al. JOURNAL OF NEUROSCIENCE
- Sphingosine 1-phosphate signaling in astrocytes: Implications for progressive multiple sclerosis
- (2016) Mauricio F. Farez et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse
- (2016) Ye Zhang et al. NEURON
- Ozanimod Treatment for Ulcerative Colitis
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Sphingosine 1-phosphate lyase ablation disrupts presynaptic architecture and function via an ubiquitin- proteasome mediated mechanism
- (2016) Daniel N. Mitroi et al. Scientific Reports
- Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis
- (2016) Ludwig Kappos et al. JAMA Neurology
- Rebound Syndrome in Patients With Multiple Sclerosis After Cessation of Fingolimod Treatment
- (2016) Stacy Ellen Hatcher et al. JAMA Neurology
- Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases
- (2016) Daniele D’Ambrosio et al. Therapeutic Advances in Chronic Disease
- Sphingosine 1-Phosphate Receptor Modulators in Multiple Sclerosis
- (2015) Adnan M. Subei et al. CNS DRUGS
- Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy
- (2015) Richard L. Proia et al. JOURNAL OF CLINICAL INVESTIGATION
- Fingolimod induces neuroprotective factors in human astrocytes
- (2015) Franziska S. Hoffmann et al. Journal of Neuroinflammation
- Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study
- (2015) Jeffrey A Cohen et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis
- (2015) Jing Zhang et al. NEUROBIOLOGY OF DISEASE
- Enhanced remyelination following lysolecithin-induced demyelination in mice under treatment with fingolimod (FTY720)
- (2015) A. Yazdi et al. NEUROSCIENCE
- Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus
- (2015) Timothy A. Gottschalk et al. Frontiers in Immunology
- A Case of Posterior Reversible Encephalopathy Syndrome Associated with Gilenya® (Fingolimod) Treatment for Multiple Sclerosis
- (2015) Hans Lindå et al. Frontiers in Neurology
- Sphingolipids: Key Regulators of Apoptosis and Pivotal Players in Cancer Drug Resistance
- (2014) Paola Giussani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility
- (2014) Lillian Cruz-Orengo et al. JOURNAL OF CLINICAL INVESTIGATION
- Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs
- (2014) Emilie Degagné et al. JOURNAL OF CLINICAL INVESTIGATION
- An update on the biology of sphingosine 1-phosphate receptors
- (2014) Victoria A. Blaho et al. JOURNAL OF LIPID RESEARCH
- An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex
- (2014) Y. Zhang et al. JOURNAL OF NEUROSCIENCE
- Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial
- (2014) Andrea Vaclavkova et al. LANCET
- Fingolimod for the treatment of neurological diseases—state of play and future perspectives
- (2014) Robert Brunkhorst et al. Frontiers in Cellular Neuroscience
- The Sphingolipid Receptor S1PR2 Is a Receptor for Nogo-A Repressing Synaptic Plasticity
- (2014) Anissa Kempf et al. PLOS BIOLOGY
- Pharmacokinetics and pharmacodynamics of ponesimod, a selective S1P1receptor modulator, in the first-in-human study
- (2013) Patrick Brossard et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Sphingolipids and Brain Resident Macrophages in Neuroinflammation: An Emerging Aspect of Nervous System Pathology
- (2013) Emma Assi et al. Clinical & Developmental Immunology
- Sphingosine-1-phosphate receptor 2
- (2013) Mohamad Adada et al. FEBS Journal
- Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy
- (2013) Aran Groves et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Immunohistochemical detection of sphingosine-1-phosphate receptor 1 and 5 in human multiple sclerosis lesions
- (2013) Corinne Brana et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Therapeutic Use of a Selective S1P1 Receptor Modulator Ponesimod in Autoimmune Diabetes
- (2013) Sylvaine You et al. PLoS One
- Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator
- (2013) Shifeng Pan et al. ACS Medicinal Chemistry Letters
- Sphingosine-1-Phosphate and Lymphocyte Egress from Lymphoid Organs
- (2012) Jason G. Cyster et al. Annual Review of Immunology
- Lysophospholipids and their receptors in the central nervous system
- (2012) Ji Woong Choi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer
- (2012) J Ohotski et al. BRITISH JOURNAL OF CANCER
- The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate
- (2012) P Gergely et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cytokine inhibition as a strategy for treating systemic lupus erythematosus
- (2012) Daniel N. Clark et al. CLINICAL IMMUNOLOGY
- Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier
- (2012) Ruben van Doorn et al. Journal of Neuroinflammation
- The Clinically-tested S1P Receptor Agonists, FTY720 and BAF312, Demonstrate Subtype-Specific Bradycardia (S1P1) and Hypertension (S1P3) in Rat
- (2012) Ryan M. Fryer et al. PLoS One
- Melanoma Occurring During Treatment With Fingolimod for Multiple Sclerosis: A Case Report
- (2011) Katrin Baumann Conzett ARCHIVES OF DERMATOLOGY
- Sphingosine-1-phosphate links glycosphingolipid metabolism to neurodegeneration via a calpain-mediated mechanism
- (2011) N Hagen et al. CELL DEATH AND DIFFERENTIATION
- Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics
- (2011) Alfred H. Merrill CHEMICAL REVIEWS
- Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model
- (2011) Hye Jung Kim et al. FASEB JOURNAL
- The Selective Sphingosine 1-Phosphate Receptor 1 Agonist Ponesimod Protects against Lymphocyte-Mediated Tissue Inflammation
- (2011) L. Piali et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Bonobos Fall within the Genomic Variation of Chimpanzees
- (2011) Anne Fischer et al. PLoS One
- Neurite outgrowth inhibitor Nogo-A establishes spatial segregation and extent of oligodendrocyte myelination
- (2011) S. Y. C. Chong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High Expression of Sphingosine 1-Phosphate Receptors, S1P1 and S1P3, Sphingosine Kinase 1, and Extracellular Signal-Regulated Kinase-1/2 Is Associated with Development of Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Patients
- (2010) Carol Watson et al. AMERICAN JOURNAL OF PATHOLOGY
- Fingolimod (FTY720) Enhances Remyelination Following Demyelination of Organotypic Cerebellar Slices
- (2010) Veronique E. Miron et al. AMERICAN JOURNAL OF PATHOLOGY
- Sphingosine-1-Phosphate Receptor-2 Function in Myeloid Cells Regulates Vascular Inflammation and Atherosclerosis
- (2010) Athanasia Skoura et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model
- (2010) Sachi Tsunemi et al. CLINICAL IMMUNOLOGY
- Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
- (2010) Jerold Chun et al. CLINICAL NEUROPHARMACOLOGY
- Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions
- (2010) Ruben Van Doorn et al. GLIA
- Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo
- (2010) Masaru Ishii et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cell-surface residence of sphingosine 1-phosphate receptor 1 on lymphocytes determines lymphocyte egress kinetics
- (2010) Shobha Thangada et al. JOURNAL OF EXPERIMENTAL MEDICINE
- 2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P1Receptor Agonists
- (2010) Martin H. Bolli et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
- (2010) J. W. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Subcellular Origin of Sphingosine 1-Phosphate Is Essential for Its Toxic Effect in Lyase-deficient Neurons
- (2009) Nadine Hagen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors
- (2009) Florian Mullershausen et al. Nature Chemical Biology
- Specific and overlapping sphingosine-1-phosphate receptor functions in human synoviocytes: impact of TNF-α
- (2008) Chenqi Zhao et al. JOURNAL OF LIPID RESEARCH
- FTY720 modulates human oligodendrocyte progenitor process extension and survival
- (2007) Veronique E. Miron et al. ANNALS OF NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now